Ads
related to: Enbrel- Treatment Savings
You May Be Eligible To Save.
Copay As Low As $0.
- RA Stories
Real People Talk About Their
Rheumatoid Arthritis Journey
- Injection Video
Learn How To Take This Medication.
Watch The Patient Tutorial.
- Sign Up For Support
Sign Up Today For Resources.
Learn Useful Info About RA.
- Treatment Savings
Search results
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 18 hours agoThe company also "tweaked" their forward guidance and the stock was raised to a fundamental...
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 48 minutes agoGlobal Reach and Market Share: With a presence in over 100 countries, Amgen Inc has established a significant global footprint. Its leading products,...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 14 hours agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Amgen shares jump after teasing ‘encouraging’ weight loss data
KFGO· 20 hours ago(Reuters) - U.S. drugmaker Amgen's shares jumped 13% to $316.26 premarket on Friday as the company...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters via AOL· 1 day ago(Reuters) -Amgen on Thursday said it was very encouraged after completing an interim analysis of its...
Amgen First-Quarter Profit Dips 1%, Revenue Rises 22%
US News & World Report· 1 day agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Analyst Report: Amgen Inc.
Morningstar Research via Yahoo Finance· 16 hours agoAmgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel ...
Q1 2024 Ardelyx Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoLet me begin with Enbrel. Our confidence in this product is driven by the strength of the fundamentals driving its earnings performance. Hcps are evolving their treatment ...
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Zacks via Yahoo Finance· 1 day agoThe headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter...
AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Fontana Herald News· 1 day agoAmgen (NASDAQ:AMGN) today announced financial results for the first quarter 2024. "With many of our innovative products delivering strong growth and promising new medicines advancing through ...
Ads
related to: Enbrel
